BRIEF-AzurRx Biopharma Activates New Clinical Trial Sites In India For Phase 2 Trial Of Covid-19 Gastrointestinal Infections Treatment

Reuters
10 Sep 2021

Sept 10 (Reuters) - AzurRx BioPharma Inc :

* AZURRX BIOPHARMA ACTIVATES NEW CLINICAL TRIAL SITES IN INDIA FOR PHASE 2 RESERVOIR TRIAL EVALUATING NICLOSAMIDE FOR THE TREATMENT OF COVID-19 GASTROINTESTINAL INFECTIONS

* AZURRX BIOPHARMA INC - ANNOUNCED ACTIVATION OF 7 NEW CLINICAL TRIAL SITES IN INDIA FOR ONGOING RESERVOIR TRIAL EVALUATING FW-1022

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10